Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Germain, Michael J
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -	Terminated	3	667	Europe, Japan, US, RoW	Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule	Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC	Autosomal Dominant Polycystic Kidney, ADPKD	08/23	08/23
REGEN-006, NCT05099770: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Recruiting	3	685	Europe, Canada, US, RoW	Renal Autologous Cell Therapy (REACT), Sham Comparator	Prokidney, Iqvia Pty Ltd, PPD	Type 2 Diabetes Mellitus, Chronic Kidney Diseases	02/27	02/27
ProActive, NCT04091984: The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry	Active, not recruiting	N/A	5000	US	Prospera	Natera, Inc., University of Maryland	Kidney Transplant Rejection	10/26	10/27